Hamerly, TimothyEverett, Jake A.Paris, NinaFisher, Steve T.Karunamurthy, ArivarasanJames, Garth A.Rumbaugh, Kendra P.Rhoads, Daniel D.Bothner, Brian2018-04-062018-04-062017-12Hamerly T, JA Everett, N Paris, ST Fisher, A Karunamurthy, GA James, KP Rumbaugh, DD Rhoads, B Bothner, “Detection of Pseudomonas aeruginosa biomarkers from thermally injured mice in situ using imaging mass spectrometry,” Analytical Biochemistry, December 2017; 539:144-148. doi: 10.1016/j.ab.2017.10.012.0003-2697https://scholarworks.montana.edu/handle/1/14486Monitoring patients with burn wounds for infection is standard practice because failure to rapidly and specifically identify a pathogen can result in poor clinical outcomes, including death. Therefore, a method that facilitates detection and identification of pathogens in situ within minutes of biopsy would be a significant benefit to clinicians. Mass spectrometry is rapidly becoming a standard tool in clinical settings, capable of identifying specific pathogens from complex samples. Imaging mass spectrometry (IMS) expands the information content by enabling spatial resolution of biomarkers in tissue samples as in histology, without the need for specific stains/antibodies. Herein, a murine model of thermal injury was used to study infection of burn tissue by Pseudomonas aeruginosa. This is the first use of IMS to detect P. aeruginosa infection in situ from thermally injured tissue. Multiple molecular features could be spatially resolved to infected or uninfected tissue. This demonstrates the potential use of IMS in a clinical setting to aid doctors in identifying both presence and species of pathogens in tissue.Article